Phage therapy holds promise in fighting against antimicrobial resistance: Dr. Kalyan Chakravarthy

Researchers are exploring phage therapy as a promising alternative to antibiotics for treating antimicrobial resistance. The team, led by Dr. Kalyan Chakravarthy, is collaborating with international institutions to advance the availability of this treatment in India.
Why it matters
Antimicrobial resistance is a growing global health crisis, and phage therapy offers a targeted approach to treating infections that no longer respond to traditional drugs.
GUNTUR Phage therapy, which uses bacteriophages to selectively eliminate harmful bacteria, holds significant potential in combating antimicrobial resistance (AMR), said Dr. Kalyan Chakravarthy Koganti, sepsis and infectious diseases specialist at SHRI Hospital, Guntur. He said this while sharing his research experience in a press release, after presenting his team's scientific findings at an international symposium jointly organised by the Chinese University of Hong Kong and reputed biomedical research journals. Dr. Kalyan Chakravarthy said his team's research presentation on phage therapy received appreciation from participants at the symposium. Dr.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in